Global Tyrosine Kinase Inhibitors Market Report 2023-2028, Featuring Profiles of Major Players including Astrazeneca, Bayer, Bristol-Myers Squibb, Eisai, F. Hoffmann-La Roche, Novartis and Pfizer
DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Tyrosine Kinase Inhibitors: Global Market Outlook” report has been added to ResearchAndMarkets.com’s offering.
The report provides an overview of the global tyrosine kinase inhibitor market and analyzes market trends. The report covers the market for tyrosine kinase inhibitors with regard to the user base across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape.
The report estimates the global market for tyrosine kinase inhibitors in 2022 and provides projections for the expected market size through 2028. The scope of the study includes tyrosine kinase inhibitor drugs that are already available in the market as well as future prospects.
Report Includes
An overview of the global market for tyrosine kinase inhibitorsAnalyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028Definition of tyrosine kinase inhibitors and their characteristics, and coverage of the market’s dynamics, specifically drivers, inhibitors and opportunitiesDiscussions of novel tyrosine kinase inhibitors and their utility in the human trialsExamination of the technologies and methods used for the creation of novel targets and their therapeutic approachesDiscussions of market challenges and how to overcome them if the market is to reach its commercialization potential, pipeline drugs and relevant patentsInformation on recent mergers and acquisitions, collaborations, partnerships and product introductionsProfiles of major players in the market, including Astrazeneca, Bayer, Boehringer Ingelheim International, Bristol-Myers Squibb , Eisai, F. Hoffmann-La Roche, Johnson & Johnson Services , Novartis and Pfizer
The study aims to estimate the size of the tyrosine kinase inhibitor market at global and regional levels and to explore market dynamics such as drivers, restraints, opportunities, and trends that impact market growth. Types and applications of tyrosine kinase inhibitors are also discussed in the report, with emphasis on the usage of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and provides a summary of patents.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Market OutlookMarket Summary
Chapter 3 Market Overview
Kinase InhibitorsTypes of Kinase InhibitorsTyrosine Kinase InhibitorsRegulatory ScenarioMarket Dynamics
Chapter 4 Market Breakdown by Type and Application
Market for Tyrosine Kinase Inhibitors, by TypeReceptor Tyrosine Kinase InhibitorsNon-receptor Tyrosine Kinase InhibitorsMarket for Tyrosine Kinase Inhibitors, by ApplicationLung CancerChronic Myelogenous Leukemia (CML)
Chapter 5 Market Breakdown by Region
Chapter 6 ESG Development
Chapter 7 Industry Structure
Ranking of Top CompaniesPipeline AnalysisPatent AnalysisEmerging Trends
Chapter 8 Company Profiles
AstrazenecaBayerBoehringer Ingelheim InternationalBristol-Myers Squibb EisaiF. Hoffmann-La RocheJohnson & Johnson Services NovartisPfizer
For more information about this report visit https://www.researchandmarkets.com/r/mq9gar
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
You may also like
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Subgroup experienced efficacy and safety consistent with overall study population Advanced malignant
Coway Announces Financial Results for Q4 and FY2023
Coway’s 2023 Q4 revenue reached KRW 1,004.4 billion (+2.5% YoY) with an operating profit amoun
Air Products Membrane Solutions Announces Membrane-Based Nitrogen Generation System Milestone with 2,000th Seagoing Vessel
LEHIGH VALLEY, Pa., Nov. 30, 2023 /PRNewswire/ — Air Products (NYSE: APD), the global leader i
